These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


184 related items for PubMed ID: 12055317

  • 1. Fat distribution and insulin sensitivity in postmenopausal women: influence of hormone replacement.
    Munoz J, Derstine A, Gower BA.
    Obes Res; 2002 Jun; 10(6):424-31. PubMed ID: 12055317
    [Abstract] [Full Text] [Related]

  • 2. Changes in intra-abdominal fat in early postmenopausal women: effects of hormone use.
    Gower BA, Muñoz J, Desmond R, Hilario-Hailey T, Jiao X.
    Obesity (Silver Spring); 2006 Jun; 14(6):1046-55. PubMed ID: 16861610
    [Abstract] [Full Text] [Related]

  • 3. Leptin in postmenopausal women: influence of hormone therapy, insulin, and fat distribution.
    Gower BA, Nagy TR, Goran MI, Smith A, Kent E.
    J Clin Endocrinol Metab; 2000 May; 85(5):1770-5. PubMed ID: 10843150
    [Abstract] [Full Text] [Related]

  • 4. Impact of visceral fat on blood pressure and insulin sensitivity in hypertensive obese women.
    Faria AN, Ribeiro Filho FF, Gouveia Ferreira SR, Zanella MT.
    Obes Res; 2002 Dec; 10(12):1203-6. PubMed ID: 12490663
    [Abstract] [Full Text] [Related]

  • 5. Physical activity, body fat, and serum C-reactive protein in postmenopausal women with and without hormone replacement.
    Manns PJ, Williams DP, Snow CM, Wander RC.
    Am J Hum Biol; 2003 Dec; 15(1):91-100. PubMed ID: 12552583
    [Abstract] [Full Text] [Related]

  • 6. Relationships of insulin sensitivity with fatness and fitness and in older men and women.
    Ouyang P, Sung J, Kelemen MD, Hees PS, DeRegis JR, Turner KL, Bacher AC, Stewart KJ.
    J Womens Health (Larchmt); 2004 Mar; 13(2):177-85. PubMed ID: 15072732
    [Abstract] [Full Text] [Related]

  • 7. Regional body fat distribution and metabolic profile in postmenopausal women.
    Piché ME, Lapointe A, Weisnagel SJ, Corneau L, Nadeau A, Bergeron J, Lemieux S.
    Metabolism; 2008 Aug; 57(8):1101-7. PubMed ID: 18640388
    [Abstract] [Full Text] [Related]

  • 8. Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy.
    Sørensen MB, Rosenfalck AM, Højgaard L, Ottesen B.
    Obes Res; 2001 Oct; 9(10):622-6. PubMed ID: 11595778
    [Abstract] [Full Text] [Related]

  • 9. Regional fat mass by DXA: high leg fat mass attenuates the relative risk of insulin resistance and dyslipidaemia in obese but not in overweight postmenopausal women.
    Aasen G, Fagertun H, Halse J.
    Scand J Clin Lab Invest; 2008 Oct; 68(3):204-11. PubMed ID: 18446527
    [Abstract] [Full Text] [Related]

  • 10. Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women.
    Thomas T, Burguera B, Melton LJ, Atkinson EJ, O'Fallon WM, Riggs BL, Khosla S.
    Metabolism; 2000 Oct; 49(10):1278-84. PubMed ID: 11079816
    [Abstract] [Full Text] [Related]

  • 11. Body fat distribution modulates insulin sensitivity in post-menopausal overweight and obese women: a MONET study.
    Tousignant B, Faraj M, Conus F, Garrel D, Brochu M, Rabasa-Lhoret R, Coderre L.
    Int J Obes (Lond); 2008 Nov; 32(11):1626-32. PubMed ID: 18838980
    [Abstract] [Full Text] [Related]

  • 12. Dysregulation of the autonomic nervous system can be a link between visceral adiposity and insulin resistance.
    Lindmark S, Lönn L, Wiklund U, Tufvesson M, Olsson T, Eriksson JW.
    Obes Res; 2005 Apr; 13(4):717-28. PubMed ID: 15897481
    [Abstract] [Full Text] [Related]

  • 13. Contribution of the lean body mass to insulin resistance in postmenopausal women with visceral obesity: a Monet study.
    Brochu M, Mathieu ME, Karelis AD, Doucet E, Lavoie ME, Garrel D, Rabasa-Lhoret R.
    Obesity (Silver Spring); 2008 May; 16(5):1085-93. PubMed ID: 18356851
    [Abstract] [Full Text] [Related]

  • 14. Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene.
    Tommaselli GA, Di Carlo C, Di Spiezio Sardo A, Bifulco G, Cirillo D, Guida M, Capasso R, Nappi C.
    Menopause; 2006 May; 13(4):660-8. PubMed ID: 16837888
    [Abstract] [Full Text] [Related]

  • 15. Relationship between hormone replacement therapy use with body fat distribution and insulin sensitivity in obese postmenopausal women.
    Sites CK, Brochu M, Tchernof A, Poehlman ET.
    Metabolism; 2001 Jul; 50(7):835-40. PubMed ID: 11436191
    [Abstract] [Full Text] [Related]

  • 16. Effect of climacteric transition and hormone replacement therapy on body weight and body fat distribution.
    Genazzani AR, Gambacciani M.
    Gynecol Endocrinol; 2006 Mar; 22(3):145-50. PubMed ID: 16835076
    [Abstract] [Full Text] [Related]

  • 17. Cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase activities in hispanic and anglo postmenopausal women: associations with total and regional body fat.
    Greaves KA, Going SB, Fernandez ML, Milliken LA, Lohman TG, Bassford T, McNamara DJ.
    Metabolism; 2003 Mar; 52(3):282-9. PubMed ID: 12647264
    [Abstract] [Full Text] [Related]

  • 18. Effects of estrogen replacement therapy on abdominal fat compartments as related to glucose and lipid metabolism in early postmenopausal women.
    Mattiasson I, Rendell M, Törnquist C, Jeppsson S, Hulthén UL.
    Horm Metab Res; 2002 Oct; 34(10):583-8. PubMed ID: 12439787
    [Abstract] [Full Text] [Related]

  • 19. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG.
    Ann Acad Med Stetin; 2002 Oct; 48():283-300. PubMed ID: 14601484
    [Abstract] [Full Text] [Related]

  • 20. Relationships between plasma leptin levels and body composition parameters measured by different methods in postmenopausal women.
    Jürimäe T, Sudi K, Jürimäe J, Payerl D, Rüütel K.
    Am J Hum Biol; 2003 Oct; 15(5):628-36. PubMed ID: 12953174
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.